Cargando…

异长春花碱逆转肺癌顺铂耐药A549/DDP细胞耐药性的作用和机制

BACKGROUND AND OBJECTIVE: Drug resistance is a major obstacle on lung cancer treatment and Vinorelbine is an effective drug to inhibition of tumor proliferation and metastasis. In this study, we investigated the effect and mechanism of Vinorelbine on reversing the cisplatin resistance of human lung...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000056/
https://www.ncbi.nlm.nih.gov/pubmed/24581167
http://dx.doi.org/10.3779/j.issn.1009-3419.2014.02.14
_version_ 1783331604312096768
collection PubMed
description BACKGROUND AND OBJECTIVE: Drug resistance is a major obstacle on lung cancer treatment and Vinorelbine is an effective drug to inhibition of tumor proliferation and metastasis. In this study, we investigated the effect and mechanism of Vinorelbine on reversing the cisplatin resistance of human lung cancer A549/DDP cell line. METHODS: With 1 μmol/L and 5 μmol/L Vinorelbine treatment, MTS assay was employed to determine the effect of the cisplatin sensitivity of tumor cells, flow cytometry to determine the apoptosis rate and change of Rh-123 content; Western blot to determine the expression of MDR1, Bcl-2, surviving, PTEN, caspase-3/8 and phosphorylation level of Akt (p-Akt); Real-time PCR was to determine the mRNA expression of MDR1, Bcl-2, survivin and PTEN. Finally the transcriptional activities of NF-κB, Twist and Snail were determined by reporter gene system. RESULTS: With 1 μmol/L and 5 μmol/L Vinorelbine treatment, the sensitivity of cancer cells to cisplatin was increased by 1.91- and 2.54- folds respectively, flow cytometry showed that the content of Rh-123 was elevated 1.93- and 2.95- folds and apoptosis rate was increased 2.25- and 3.82- folds, Western blot showed that the expression of multidrug resistance related proteins MDR, Bcl-2 and survivin were downregulated, caspase-3/8 and PTEN was upregulated, phosphorylation of Akt was downregulated as well, real-time assay showed that the mRNA expression of MDR1 was downregulated 43.5% and 25.8%, Bcl-2 was downregulated 57.3% and 34.1%, survivin was downregulated 37.6% and 12.4%, PTEN was upregulated 183.4% and 154.2%, the transcriptional activities of NF-κB was downregulated 53.2% and 34.5%, Twist was downregulated 61.4% and 33.5%, and Snail was downregulated 57.8% and 18.7%. CONCLUSION: Vinorelbine treatment led to increase of cisplatin sensitivity of A549/DDP cells and the mechanisms included the regulation of PTEN/AKT/NF-κB signal pathway to decreased drug resistance gene expression and increased pro-apoptosis gene expression.
format Online
Article
Text
id pubmed-6000056
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-60000562018-07-06 异长春花碱逆转肺癌顺铂耐药A549/DDP细胞耐药性的作用和机制 Zhongguo Fei Ai Za Zhi 基础研究 BACKGROUND AND OBJECTIVE: Drug resistance is a major obstacle on lung cancer treatment and Vinorelbine is an effective drug to inhibition of tumor proliferation and metastasis. In this study, we investigated the effect and mechanism of Vinorelbine on reversing the cisplatin resistance of human lung cancer A549/DDP cell line. METHODS: With 1 μmol/L and 5 μmol/L Vinorelbine treatment, MTS assay was employed to determine the effect of the cisplatin sensitivity of tumor cells, flow cytometry to determine the apoptosis rate and change of Rh-123 content; Western blot to determine the expression of MDR1, Bcl-2, surviving, PTEN, caspase-3/8 and phosphorylation level of Akt (p-Akt); Real-time PCR was to determine the mRNA expression of MDR1, Bcl-2, survivin and PTEN. Finally the transcriptional activities of NF-κB, Twist and Snail were determined by reporter gene system. RESULTS: With 1 μmol/L and 5 μmol/L Vinorelbine treatment, the sensitivity of cancer cells to cisplatin was increased by 1.91- and 2.54- folds respectively, flow cytometry showed that the content of Rh-123 was elevated 1.93- and 2.95- folds and apoptosis rate was increased 2.25- and 3.82- folds, Western blot showed that the expression of multidrug resistance related proteins MDR, Bcl-2 and survivin were downregulated, caspase-3/8 and PTEN was upregulated, phosphorylation of Akt was downregulated as well, real-time assay showed that the mRNA expression of MDR1 was downregulated 43.5% and 25.8%, Bcl-2 was downregulated 57.3% and 34.1%, survivin was downregulated 37.6% and 12.4%, PTEN was upregulated 183.4% and 154.2%, the transcriptional activities of NF-κB was downregulated 53.2% and 34.5%, Twist was downregulated 61.4% and 33.5%, and Snail was downregulated 57.8% and 18.7%. CONCLUSION: Vinorelbine treatment led to increase of cisplatin sensitivity of A549/DDP cells and the mechanisms included the regulation of PTEN/AKT/NF-κB signal pathway to decreased drug resistance gene expression and increased pro-apoptosis gene expression. 中国肺癌杂志编辑部 2014-02-20 /pmc/articles/PMC6000056/ /pubmed/24581167 http://dx.doi.org/10.3779/j.issn.1009-3419.2014.02.14 Text en 版权所有©《中国肺癌杂志》编辑部2014 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/
spellingShingle 基础研究
异长春花碱逆转肺癌顺铂耐药A549/DDP细胞耐药性的作用和机制
title 异长春花碱逆转肺癌顺铂耐药A549/DDP细胞耐药性的作用和机制
title_full 异长春花碱逆转肺癌顺铂耐药A549/DDP细胞耐药性的作用和机制
title_fullStr 异长春花碱逆转肺癌顺铂耐药A549/DDP细胞耐药性的作用和机制
title_full_unstemmed 异长春花碱逆转肺癌顺铂耐药A549/DDP细胞耐药性的作用和机制
title_short 异长春花碱逆转肺癌顺铂耐药A549/DDP细胞耐药性的作用和机制
title_sort 异长春花碱逆转肺癌顺铂耐药a549/ddp细胞耐药性的作用和机制
topic 基础研究
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000056/
https://www.ncbi.nlm.nih.gov/pubmed/24581167
http://dx.doi.org/10.3779/j.issn.1009-3419.2014.02.14
work_keys_str_mv AT yìzhǎngchūnhuājiǎnnìzhuǎnfèiáishùnbónàiyàoa549ddpxìbāonàiyàoxìngdezuòyònghéjīzhì
AT yìzhǎngchūnhuājiǎnnìzhuǎnfèiáishùnbónàiyàoa549ddpxìbāonàiyàoxìngdezuòyònghéjīzhì
AT yìzhǎngchūnhuājiǎnnìzhuǎnfèiáishùnbónàiyàoa549ddpxìbāonàiyàoxìngdezuòyònghéjīzhì
AT yìzhǎngchūnhuājiǎnnìzhuǎnfèiáishùnbónàiyàoa549ddpxìbāonàiyàoxìngdezuòyònghéjīzhì